title: Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.
authors: E
authors: E
authors: Pope
authors: A
authors: A
authors: Chakkittakandiyil
authors: I
authors: I
authors: Lara-Corrales
authors: E
authors: E
authors: Maki
authors: M
authors: M
authors: Weinstein
mesh_terms: D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005240:Feasibility Studies; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D009248:Nadolol / Q000008:administration & dosage*; D011433:Propranolol / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D009248:Nadolol; D011433:Propranolol